Journal article
Etanercept for the treatment of rheumatoid arthritis.
- Abstract:
-
BACKGROUND: Etanercept is a soluble tumour necrosis factor alpha-receptor disease-modifying anti-rheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). OBJECTIVES: The purpose of this review was to update the previous Cochrane systematic review published in 2003 assessing the benefits and harms of etanercept for the treatment of RA. In addition, we also evaluated the benefits and harms of etanercept plus DMARD compared with DMARD monotherapy in those people with RA who are pa...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cochrane database of systematic reviews
- Volume:
- 5
- Issue:
- 5
- Pages:
- CD004525
- Publication date:
- 2013-01-01
- DOI:
- EISSN:
-
1469-493X
- ISSN:
-
1469-493X
- Source identifiers:
-
401961
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:401961
- UUID:
-
uuid:3ff200e0-2449-458f-98e7-b1d3b80d045f
- Local pid:
- pubs:401961
- Deposit date:
- 2013-11-17
Terms of use
- Copyright date:
- 2013
If you are the owner of this record, you can report an update to it here: Report update to this record